Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ACD PHARMACEUTICALS AS
AS
Active
Org 979455518
Lofoten Bio Centre Storeidøya 60, 8370
Leknes
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1997 · 28 years old
10 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ACD PHARMACEUTICALS AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
8M
17M
25M
33M
17M
2020
13M
2021
27M
2022
29M
2023
25M
2024
EBITDA
NOK millions
14M
5M
-3M
-12M
-20M
11M
2020
1M
-91%
2021
-16M
-1700%
2022
5M
+131%
2023
-4M
-180%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
17 080
12 706
26 850
29 423
24 666
Staff expenses
−105
−4 581
−14 282
−10 411
−9 331
EBITDA
11 356
1 319
−15 860
5 022
−3 671
Depreciation & amort.
−34
−34
−97
−174
−153
EBIT
11 322
1 285
−15 957
4 848
−3 824
Net financials
201
−26
−36
−469
−717
Profit before tax
11 523
1 260
−15 994
4 379
−4 542
Tax
−0
−0
−0
−0
−0
Net profit
9 116
1 145
−12 271
3 653
−967
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
25 535
16 204
24 283
32 902
75 444
Equity
11 889
13 034
14 074
15 171
13 984
Long-term debt
11
0
5 110
35
0
Short-term debt
13 636
3 171
5 099
17 696
61 461
Total debt
13 646
3 171
10 209
17 731
61 461
Financial ratios
5-year trend
EBITDA margin
-14.9%
This company
15.8%
Market median
-194% vs market
2020
2024
Equity ratio
18.5%
This company
38.2%
Market median
-52% vs market
2020
2024
Return on equity
-6.9%
This company
18.4%
Market median
-138% vs market
2020
2024
Net profit margin
-3.9%
This company
8.1%
Market median
-148% vs market
2020
2024
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
2020
2024
Debt / equity
4.40×
This company
0.62×
Market median
-610% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on ACD PHARMACEUTICALS AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
